tranexamic acid has been researched along with Infection, Postoperative Wound in 10 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A randomized double-blind trial has shown that, in 160 women with breast cancer undergoing lumpectomy or mastectomy with axillary clearance, perioperative and postoperative administration of tranexamic acid 1 g three times daily resulted in a significant reduction in the mean postoperative drainage volume compared with patients given placebo (283 versus 432 ml, P < 0." | 9.07 | Perioperative and postoperative tranexamic acid reduces the local wound complication rate after surgery for breast cancer. ( Haberthuer, F; Harder, F; Kreuter, U; Laffer, U; Oertli, D, 1994) |
| "The combined use of intraarticular topical TXA with rivaroxaban in patients undergoing TKA is a safe and effective method to reduce blood loss, the need for transfusion, and wound complications without elevating the risk of DVT." | 5.48 | Combined use of topical intraarticular tranexamic acid and rivaroxaban in total knee arthroplasty safely reduces blood loss, transfusion rates, and wound complications without increasing the risk of thrombosis. ( Kang, MW; Kim, JI; Kim, YT; Lee, JK; Lee, YM, 2018) |
| "A randomized double-blind trial has shown that, in 160 women with breast cancer undergoing lumpectomy or mastectomy with axillary clearance, perioperative and postoperative administration of tranexamic acid 1 g three times daily resulted in a significant reduction in the mean postoperative drainage volume compared with patients given placebo (283 versus 432 ml, P < 0." | 5.07 | Perioperative and postoperative tranexamic acid reduces the local wound complication rate after surgery for breast cancer. ( Haberthuer, F; Harder, F; Kreuter, U; Laffer, U; Oertli, D, 1994) |
| "Tranexamic acid (TXA) has been widely utilized to reduce blood loss and allogeneic transfusions in patients who undergo lower limb arthroplasty." | 4.40 | Tranexamic acid administration for the prevention of periprosthetic joint infection and surgical site infection: a systematic review and meta-analysis. ( Choe, H; Imanishi, K; Inaba, Y; Kamono, E; Kobayashi, N; Kumagai, K; Takagawa, S; Yukizawa, Y, 2023) |
| "Tranexamic acid (TXA) has been reported to reduce perioperative blood loss in hip joint arthroplasty." | 2.53 | Intravenous versus topical tranexamic acid in primary total hip replacement: A meta-analysis. ( Chen, P; Fang, Y; He, J; Liang, Y; Wang, J; Zhang, P, 2016) |
| "Tranexamic acid is an effective treatment to reduce blood loss." | 1.91 | The safety of tranexamic acid administration in total knee arthroplasty: a population-based study from Taiwan. ( Chen, JW; Hou, SM; Hsu, HW; Hsu, LI; Wei, ST, 2023) |
| "The combined use of intraarticular topical TXA with rivaroxaban in patients undergoing TKA is a safe and effective method to reduce blood loss, the need for transfusion, and wound complications without elevating the risk of DVT." | 1.48 | Combined use of topical intraarticular tranexamic acid and rivaroxaban in total knee arthroplasty safely reduces blood loss, transfusion rates, and wound complications without increasing the risk of thrombosis. ( Kang, MW; Kim, JI; Kim, YT; Lee, JK; Lee, YM, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hsu, LI | 3 |
| Hsu, HW | 3 |
| Chen, JW | 3 |
| Wei, ST | 3 |
| Hou, SM | 3 |
| Imanishi, K | 1 |
| Kobayashi, N | 1 |
| Kamono, E | 1 |
| Yukizawa, Y | 1 |
| Takagawa, S | 1 |
| Choe, H | 1 |
| Kumagai, K | 1 |
| Inaba, Y | 1 |
| Jacobson, RA | 1 |
| Wienholts, K | 1 |
| Williamson, AJ | 1 |
| Gaines, S | 1 |
| Hyoju, S | 1 |
| van Goor, H | 1 |
| Zaborin, A | 1 |
| Shogan, BD | 1 |
| Zaborina, O | 1 |
| Alverdy, JC | 1 |
| Kim, YT | 1 |
| Kang, MW | 1 |
| Lee, JK | 1 |
| Lee, YM | 1 |
| Kim, JI | 1 |
| Peck, J | 1 |
| Kepecs, DM | 1 |
| Mei, B | 1 |
| Safir, OA | 1 |
| Backstein, D | 1 |
| Gross, AE | 1 |
| Kuzyk, PR | 1 |
| Maniar, RN | 1 |
| Pradhan, P | 1 |
| Bhatnagar, N | 1 |
| Maniar, A | 1 |
| Bidwai, R | 1 |
| Bindal, P | 1 |
| Rasouli, MR | 1 |
| Gomes, LS | 1 |
| Parsley, B | 1 |
| Barsoum, W | 1 |
| Bezwada, H | 1 |
| Cashman, J | 1 |
| Garcia, J | 1 |
| Hamilton, W | 1 |
| Hume, E | 1 |
| Malhotra, R | 1 |
| Memtsoudis, S | 1 |
| Ong, A | 1 |
| Orozco, F | 1 |
| Padgett, D | 1 |
| Reina, R | 1 |
| Teloken, M | 1 |
| Thienpont, E | 1 |
| Waters, JH | 1 |
| Wang, C | 1 |
| Xu, GJ | 1 |
| Han, Z | 1 |
| Ma, JX | 1 |
| Ma, XL | 1 |
| Jiang, X | 1 |
| Wang, Y | 1 |
| Zhang, P | 1 |
| Liang, Y | 1 |
| Chen, P | 1 |
| Fang, Y | 1 |
| He, J | 1 |
| Wang, J | 1 |
| Oertli, D | 1 |
| Laffer, U | 1 |
| Haberthuer, F | 1 |
| Kreuter, U | 1 |
| Harder, F | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prospective Randomized Study Comparing Topical Versus Intravenous Tranexamic Acid in Anterior Total Hip Arthroplasty[NCT03359525] | Phase 4 | 114 participants (Anticipated) | Interventional | 2017-07-01 | Recruiting | ||
| Does a Single Steroid Injection Reduce the Formation of Postmastectomy Seroma[NCT00307606] | Phase 4 | 40 participants (Anticipated) | Interventional | 2005-12-31 | Recruiting | ||
| Minimization of Bleeding Complications Through Utilization of Perioperative Tranexamic Acid in Breast Surgery: A Randomized Double-blinded Placebo-controlled Trial[NCT02615366] | Phase 4 | 800 participants (Anticipated) | Interventional | 2016-02-29 | Not yet recruiting | ||
| Pilot RCT: Use of Tranexamic Acid (TXA) in Post Mastectomy Patients for Seroma and Hematoma Prevention[NCT03738527] | Phase 4 | 100 participants (Anticipated) | Interventional | 2019-10-07 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for tranexamic acid and Infection, Postoperative Wound
| Article | Year |
|---|---|
Tranexamic acid administration for the prevention of periprosthetic joint infection and surgical site infection: a systematic review and meta-analysis.
Topics: Administration, Topical; Antifibrinolytic Agents; Arthritis, Infectious; Arthroplasty, Replacement, | 2023 |
Topical application of tranexamic acid in primary total hip arthroplasty: a systemic review and meta-analysis.
Topics: Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; | 2015 |
Intravenous versus topical tranexamic acid in primary total hip replacement: A meta-analysis.
Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace | 2016 |
3 trials available for tranexamic acid and Infection, Postoperative Wound
| Article | Year |
|---|---|
Tranexamic acid administration for the prevention of periprosthetic joint infection and surgical site infection: a systematic review and meta-analysis.
Topics: Administration, Topical; Antifibrinolytic Agents; Arthritis, Infectious; Arthroplasty, Replacement, | 2023 |
Role of Suction Drain after Knee Arthroplasty in the Tranexamic Acid Era: A Randomized Controlled Study.
Topics: Aged; Analgesics, Opioid; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Edema; Female; H | 2019 |
Perioperative and postoperative tranexamic acid reduces the local wound complication rate after surgery for breast cancer.
Topics: Age Factors; Aged; Aged, 80 and over; Breast Diseases; Breast Neoplasms; Contusions; Double-Blind Me | 1994 |
Perioperative and postoperative tranexamic acid reduces the local wound complication rate after surgery for breast cancer.
Topics: Age Factors; Aged; Aged, 80 and over; Breast Diseases; Breast Neoplasms; Contusions; Double-Blind Me | 1994 |
Perioperative and postoperative tranexamic acid reduces the local wound complication rate after surgery for breast cancer.
Topics: Age Factors; Aged; Aged, 80 and over; Breast Diseases; Breast Neoplasms; Contusions; Double-Blind Me | 1994 |
Perioperative and postoperative tranexamic acid reduces the local wound complication rate after surgery for breast cancer.
Topics: Age Factors; Aged; Aged, 80 and over; Breast Diseases; Breast Neoplasms; Contusions; Double-Blind Me | 1994 |
Perioperative and postoperative tranexamic acid reduces the local wound complication rate after surgery for breast cancer.
Topics: Age Factors; Aged; Aged, 80 and over; Breast Diseases; Breast Neoplasms; Contusions; Double-Blind Me | 1994 |
Perioperative and postoperative tranexamic acid reduces the local wound complication rate after surgery for breast cancer.
Topics: Age Factors; Aged; Aged, 80 and over; Breast Diseases; Breast Neoplasms; Contusions; Double-Blind Me | 1994 |
Perioperative and postoperative tranexamic acid reduces the local wound complication rate after surgery for breast cancer.
Topics: Age Factors; Aged; Aged, 80 and over; Breast Diseases; Breast Neoplasms; Contusions; Double-Blind Me | 1994 |
Perioperative and postoperative tranexamic acid reduces the local wound complication rate after surgery for breast cancer.
Topics: Age Factors; Aged; Aged, 80 and over; Breast Diseases; Breast Neoplasms; Contusions; Double-Blind Me | 1994 |
Perioperative and postoperative tranexamic acid reduces the local wound complication rate after surgery for breast cancer.
Topics: Age Factors; Aged; Aged, 80 and over; Breast Diseases; Breast Neoplasms; Contusions; Double-Blind Me | 1994 |
5 other studies available for tranexamic acid and Infection, Postoperative Wound
| Article | Year |
|---|---|
The safety of tranexamic acid administration in total knee arthroplasty: a population-based study from Taiwan.
Topics: Administration, Intravenous; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, S | 2023 |
The safety of tranexamic acid administration in total knee arthroplasty: a population-based study from Taiwan.
Topics: Administration, Intravenous; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, S | 2023 |
The safety of tranexamic acid administration in total knee arthroplasty: a population-based study from Taiwan.
Topics: Administration, Intravenous; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, S | 2023 |
The safety of tranexamic acid administration in total knee arthroplasty: a population-based study from Taiwan.
Topics: Administration, Intravenous; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, S | 2023 |
The safety of tranexamic acid administration in total knee arthroplasty: a population-based study from Taiwan.
Topics: Administration, Intravenous; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, S | 2023 |
The safety of tranexamic acid administration in total knee arthroplasty: a population-based study from Taiwan.
Topics: Administration, Intravenous; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, S | 2023 |
The safety of tranexamic acid administration in total knee arthroplasty: a population-based study from Taiwan.
Topics: Administration, Intravenous; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, S | 2023 |
The safety of tranexamic acid administration in total knee arthroplasty: a population-based study from Taiwan.
Topics: Administration, Intravenous; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, S | 2023 |
The safety of tranexamic acid administration in total knee arthroplasty: a population-based study from Taiwan.
Topics: Administration, Intravenous; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, S | 2023 |
Topics: Animals; Anti-Bacterial Agents; Antifibrinolytic Agents; Collagen Type I; Collagen Type IV; Colon; D | 2020 |
Combined use of topical intraarticular tranexamic acid and rivaroxaban in total knee arthroplasty safely reduces blood loss, transfusion rates, and wound complications without increasing the risk of thrombosis.
Topics: Administration, Topical; Aged; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfus | 2018 |
The Effect of Preoperative Administration of Intravenous Tranexamic Acid During Revision Hip Arthroplasty: A Retrospective Study.
Topics: Acetabulum; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood | 2018 |
Blood conservation.
Topics: Anesthesia; Antifibrinolytic Agents; Arthritis, Infectious; Arthroplasty, Replacement; Blood Loss, S | 2014 |